Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 3, 2004, Pages 777-787

  De Meerleer, Gert ^a   Vakaet, Luc ^a   Meersschout, Sabine ^a   Villeirs, Geert ^a   Verbaeys, Antony ^a   Oosterlinck, Wim ^a   De Neve, Wilfried ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute toxicity; Intensity modulated radiotherapy; Prostate cancer

Indexed keywords

HOSPITALS; PATIENT MONITORING; PHOTONS; PROBLEM SOLVING; TOXICITY; TUMORS;

LOCAL CONTROL; PRIMARY TREATMENT; SEMINAL VESICLES;

RADIOTHERAPY;

AGED; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; FECES INCONTINENCE; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUESTIONNAIRE; RADIATION BEAM; RADIATION DEPTH DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM HEMORRHAGE; SCORING SYSTEM; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; COLON, SIGMOID; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RECTUM;

EID: 4744362157     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.04.017     Document Type: Article

References (32)

1. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimisation, and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510
2. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomised radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911
3. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response Results of the M.D. Anderson Phase III randomised trial. Int J Radiat Oncol Biol Phys. 53:2002;1097-1105
4. Coen J.J., Zietman A.L., Thakral H., et al. Radical radiation for localized prostate cancer Local persistence of disease results in a late wave of metastasis. JCO. 20:2002;3199-3205
5. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92
6. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 46:2000;391-402
7. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys. 34:1996;555-564
8. Ruy J.K., Winter K., Michalski J.M., et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys. 54:2002;1036-1046
9. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I) Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys. 47:2000;103-113
10. Teh B.S., Mai W.-Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization Acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys. 49:2001;705-712
11. Zelefsky M.J., Leibel S.A., Kutcher G.J., et al. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Sci Am. 1:1995;142-149
12. Kupelian A.P., Reddy C.A., Carlson T.P., et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;904-912
13. O'Brien P.C., Franklin C.I., Poulsen M.G., et al. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis Longer term follow-up of a phase III trial - Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 54:2002;442-449
14. Yeoh E.E.K., Botten R., Russo A., et al. Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys. 47:2001;915-924
15. American Joint Commission on Staging of Cancer. Manual for staging of cancer. ed. 5. Philadelphia: J. B. Lippincott; 1997
16. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300
17. Diaz A., Roach M., Marquez C., et al. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localised prostate cancer. Int J Radiat Oncol Biol Phys. 30:1994;323-329
18. De Meerleer G.O., Vakaet L.A.M.L., De Gersem W.R.T., et al. Radiotherapy of prostate cancer with or without intensity modulated beams A planning comparison. Int J Radiat Oncol Biol Phys. 47:2000;639-648
19. De Meerleer G., Villeirs G., Vakaet L., et al. The incidence of sigmoid colon and small bowel located in the vicinity of the planning target volume of localized prostate cancer [Abstract]. Eur Radiol. 13:2003;451
20. De Gersem W., Claus F., De Wagter C., et al. An anatomy-based beam segmentation tool for intensity-modulated radiation therapy and its application to head-and-neck cancer. Int J Radiat Oncol Biol Phys. 51:2001;849-859
21. De Neve W., De Gersem W., De Meerleer G., Claus F., De Wagter C. In response to Drs. Vaarkamp and Krasin. Int J Radiat Oncol Biol Phys. 49:2001;1519-1520
22. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 53:2002;1111-1116
23. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys. 31:1995;1341-1346
24. Yeoh E.E.K., Fraser R.J., McGowan R.E., et al. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma Early results of a phase III randomized trial. Int J Radiat Oncol Biol Phys. 55:2003;943-955
25. Intensity modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 1998;51:880-914
26. Nuyttens J.J., Milito S., Rust P.F., Turrisi A.T. III. Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol. 64:2002;209-214
27. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-1116
28. Lawton C.A., Won M., Pilepich M.V., et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:1991;935-939
29. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., Rosen I. Complications from radiotherapy dose escalation in prostate cancer Preliminary results of a randomised trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642
30. Wachter S., Gerstner N., Goldner G., Pötzi R., Wambersie A., Pötter R. Rectal sequelae after conformal radiotherapy of prostate cancer Dose-volume histograms as predictive factors. Radiother Oncol. 59:2001;65-70
31. Zelefsky M.J., Fuks Z., Wolfe T., et al. Locally advanced prostatic cancer Long term toxicity outcome after three-dimensional conformal radiation therapy - A dose-escalation study. Radiology. 209:1998;169-174
32. Patel R.R., Orton N., Tomé W.A., Chappell R., Ritter M.A. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol. 67:2003;285-294